Arbutus Biopharma's total assets for Q1 2026 were $277.16M, an increase of 192.93% from the previous quarter. ABUS total liabilities were $16.99M for the fiscal quarter, a -5.85% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.